ConV2X Expands Cambridge Executive Summit With New Healthcare, FDA, AI, and Cybersecurity Leaders

ConV2X today announced a new group of in-person speakers joining its September 24–25 executive summit at The Foundry in Cambridge, Massachusetts, expanding the multidisciplinary dialogue around AI infrastructure, decentralized health, cybersecurity, regulation, clinical implementation and the technologies reshaping healthcare and life sciences.

The newly announced in-person participants bring experience from healthcare delivery, FDA leadership and regulation, enterprise AI, cybersecurity, technology strategy and emerging infrastructure:

· Cesar Koirala — CEO, HumanLens.ai; former Optum AI Ethics Director

· Dr. Arsh Arora — Lead, AI & Cyber IR Operations, McKesson

· Honorable John Norris, JD — Executive Chairman, Safely2Prosperity; former Principal Deputy Commissioner, FDA

· Edward John Allera — Of Counsel, Life Sciences / FDA & Biotechnology, Buchanan Ingersoll & Rooney

· Dr. Holland Haynie — CMO, Central Ozarks Medical Center

· Gabriel Millien — Technology & AI Strategy Advisor, Galson Research

· Alice Milshtein — Senior AI Architect, Eltegra

· Tory Cenaj — Founder, CEO & Publisher, Partners in Digital Health, ConV2X

The program focuses on challenges facing healthcare and life sciences on how organizations are moving technologies into trusted, secure, and operationally viable systems.

ConV2X has released an executive roundtable examining the accelerating convergence of four powerful technology domains:

AI: GENOMICS: BLOCKCHAIN: QUANTUM

The discussion brings together leaders working across medicine, artificial intelligence, longevity, data science, genomics and decentralized technologies:

• Ingrid Vasiliu-Feltes, MD, EMBA, FAPA, FACHE — University of Miami Herbert Business School; Institute SEI
• Carlos D. Bustamante, PhD — University of Oklahoma; Mohamed bin Zayed University of Artificial Intelligence (MBZUAI)
• Evelyne Bischof, MD, PhD — Shanghai University of Medicine and Health Sciences; Sheba Longevity Institute; Tel Aviv University School of Medicine
• Stephen J. Dennis, MSEE, MBA — University of Miami Frost Institute for Data Science and Computing; Softhread

The roundtable explores what happens as advances in artificial intelligence, genomics and multiomics, decentralized infrastructure, blockchain and quantum technologies increasingly intersect within precision health.

A companion article, “The Convergence Reshaping Precision Health: AI: Genomics: Blockchain: Quantum,” is awaiting publication in the August issue of Blockchain in Healthcare Today Platform Approaches Journal (BHTY).

ConV2X convenes multidisciplinary leaders to examine the infrastructure and strategies required to responsibly implement and scale next gen intelligent health systems, featuring use cases and deep dive discussions. The September summit focuses on AI infrastructure, decentralized systems, interoperability, governance, cybersecurity, digital trust, clinical innovation, and blockchain with an emphasis on real world problem solving.

ConV2X 2026
September 24–25, 2026 The Foundry 101 Rogers Street: Cambridge, Massachusetts

Program, speakers and registration:
ConV2X Why Attend and Registration

A special ConV2X Researcher Rate is available through August 31, 2026.

Access the Special Researcher Rate

ConV2X is an in-person executive summit produced by Partners in Digital Health, bringing together multidisciplinary leaders across healthcare, life sciences, technology, research and regulation to advance practical transformation and address shared challenges surrounding emerging technologies and trusted health infrastructure. https://conv2xsymposium.com

Blockchain in Healthcare Today Platform Approaches Journal (BHTY) is a peer-reviewed journal focused on blockchain, decentralized and platform technologies and emerging digital infrastructure across healthcare and life sciences. Visit BHTY

Contact Information

Tory Cenaj

Founder and Publisher

Partners in Digital Health

(1) 2032433063

t.cenaj@partnersindigitalhealth.com